M
Michael F. Costello
Researcher at University of New South Wales
Publications - 61
Citations - 3661
Michael F. Costello is an academic researcher from University of New South Wales. The author has contributed to research in topics: Polycystic ovary & Infertility. The author has an hindex of 24, co-authored 57 publications receiving 2869 citations. Previous affiliations of Michael F. Costello include National Health and Medical Research Council & Royal Hospital for Women.
Papers
More filters
Journal ArticleDOI
Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Helena J. Teede,Helena J. Teede,Marie Misso,Marie Misso,Michael F. Costello,Anuja Dokras,Joop S.E. Laven,Lisa J. Moran,Lisa J. Moran,Terhi Piltonen,Robert J. Norman,Robert J. Norman,Marianne Andersen,Ricardo Azziz,Adam H. Balen,Estifanos Baye,Jacqueline Boyle,Leah Brennan,Frank J.M. Broekmans,Preeti Dabadghao,Luigi Devoto,Didier Dewailly,Linda Downes,Bart C.J.M. Fauser,Stephen Franks,Rhonda Garad,Melanie Gibson-Helm,Cheryce L. Harrison,Roger Hart,Rachel Hawkes,Angelica Lindén Hirschberg,Kathleen M. Hoeger,Femke P Hohmann,Samantha K. Hutchison,Anju E. Joham,Louise Johnson,Cailin Jordan,Jayashri Kulkarni,Richard S. Legro,Rong Li,Marla E. Lujan,Jaideep Malhotra,Darren Mansfield,Kate Marsh,Veryan McAllister,Edgar Mocanu,Ben W.J. Mol,Ernest Hung Yu Ng,Sharon E. Oberfield,Sasha Ottey,Alexia S Peña,Jie Qiao,Leanne M. Redman,Raymond J. Rodgers,Luk Rombauts,Daniela Romualdi,Duru Shah,Jane Speight,Poli Mara Spritzer,Elisabet Stener-Victorin,Nigel K. Stepto,Juha S. Tapanainen,Eliza C. Tassone,Shakila Thangaratinam,Mala Thondan,Chii Ruey Tzeng,Zephne M van der Spuy,Eszter Vanky,Maria G. Vogiatzi,Angela Wan,Chandrika N Wijeyaratne,Selma F. Witchel,Jane Woolcock,Bulent O. Yildiz +73 more
TL;DR: The international guideline for the assessment and management of PCOS provides clinicians with clear advice on best practice based on the best available evidence, expert multidisciplinary input and consumer preferences to promote consistent, evidence-based care and improve the experience and health outcomes of women with PCOS.
Journal ArticleDOI
Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline
Helena J. Teede,Marie Misso,Amanda Deeks,Lisa J. Moran,Bronwyn G. A. Stuckey,Bronwyn G. A. Stuckey,Jennifer Wong,Robert J. Norman,Michael F. Costello,Michael F. Costello +9 more
TL;DR: The Guideline Development Groups aim to provide evidence-based advice to policymakers and practitioners on how to improve the quality of public services and promote sustainable development in the developing world.
Journal ArticleDOI
A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome.
TL;DR: The effectiveness and role of metformin in the treatment of PCOS anovulatory infertility in clinical practice is difficult to assess and further well-designed prospective, perhaps multicenter, randomized controlled trials with the primary end point of pregnancy or live-birth rate are required.
Journal ArticleDOI
Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome
Leopoldo O Tso,Michael F. Costello,Luiz Eduardo T Albuquerque,Régis B Andriolo,Cristiane R Macedo +4 more
TL;DR: The findings suggest that for a woman with a 32 % chance of achieving a live birth using placebo or other treatment, the corresponding chance using metformin treatment would be between 28% and 53%.
Journal ArticleDOI
Insulin‐sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome
TL;DR: Up to 12-months treatment with the OCP is associated with an improvement in menstrual pattern and serum androgen levels compared with metformin; but met formin treatment results in a reduction in fasting insulin and lower triglyceride levels than with theOCP.